tech transfer


Best of mendelspod - Highlights 2011

Podcast Sponsor: Ingenuity- iReport: The fastest way to get meaning from your expression data

Listen (3:50) Steve Burill: New Model for Big Pharma

Listen (7:06) Dan Vorhaus: The Myriad Case

Listen (3:36) Russ Altman: Personal Genomics and Patent Law

Listen (3:43) Mike Snyder: Million Dollar Interpretation

Listen (2:50) Howard McLeod: PGENI

Listen (2:08) Jonathan Eisen: Why Open Science?

Listen (3:12) George Church: Scientists and the Public

Listen (4:25) Ron Davis: Fit Between University and Industry

Listen (3:01) Greg Scott-Will China Soon Have a Steve Jobs?

As we approach the last day of 2011, we thought we’d look back and bring you highlights of the year, the very best of mendelspod. Included in today’s show are snippets from industry leaders on personalized medicine, the evolution of big pharma, gene patents, and thoughts on open science.

NOTE: It’s important to acknowledge that mendelspod has been made possible through the generous support of our sponsors throughout the year. We thank all of them for their partnership. We wish them and all of you a very happy holiday.

Bringing Engineers to Medicine with Dr. Ron Davis, Stanford Genome Center

Podcast Sponsor: Ingenuity - The fastest way to obtain biological meaning from your expression data. Get a free iReport

Guest:

Dr. Ron Davis, Director, Stanford Genome Technology Center, Bio and Contact Info

Money from prize to research chronic fatique syndrome Listen (2:04) Money from prize to research chronic fatique syndrome

Bringing engineers to clinical medicine Listen (6:48) Bringing engineers to clinical medicine

Fit between university lab and commercial development Listen (8:04) Fit between university lab and commercial development

Fan of targeted analysis of genome Listen (5:47) Fan of targeted analysis of genome

Should scientists engage general public? Listen (3:17) Should scientists engage general public?

What about technology drives you? Listen (6:32) What about technology drives you?

Is NIH funding academic welfare? Listen (3:29) Is NIH funding academic welfare?

Thoughts on 'open science' Listen (11:18) Thoughts on 'open science'

How do you characterize yourself? Listen (1:33) How do you characterize yourself?

We’re delighted to welcome to mendelspod a veteran of the life science arena, Dr. Ron Davis. He’s the director of the Stanford Genome Technology Center and winner of this year’s Gruber Genetics Prize. The prize was presented to Ron a couple weeks ago at the ASHG ho-down in Montreal. Ron has been a leader in the area of genomics and high throughput biochemical techniques and been involved in the spinoff of multiple start-up companies from his lab at Stanford. He’s a co-founder of ParAllele, a company later purchased by Affymetrix and is former advisor to Ion Torrent, whose semiconductor sequencing technology is dramatically reducing the cost of sequencing.

Ron shares with us some of the current technology that he's working on and talks about how he goes about it. In a very candid interview, Ron talks about issues around NIH funding and the growing 'open science' movement.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup